Photoimmunotherapy - novel therapeutic strategy for glioblastoma.
2017/25/B/NZ5/00039
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ5_5: Diagnostyka chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 7
Call
OPUS 13 – announced on 2017-03-15
- Amount awarded
- 1 647 680 PLN
- Project start date
- 2018-01-12
- Project end date
- 2022-11-11
- Project duration
- 58 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.
- Authors:
- Justyna Mączyńska, Florian Raes, Chiara Da Pieve, Stephen Turnock, Jessica K R Boult, Julia Hoebart, Marcin Niedbala, Simon P Robinson, Kevin J Harrington, Wojciech Kaspera, Gabriela Kramer-Marek
- Academic press:
- BMC Medicine (year: 2022, volume: 20, pages: 46039), Publisher: Springer
- Status:
- Published
- DOI:
- 10.1186/s12916-022-02388-z10.1186/s12916-022-02388-z – link to the publication